Ultomiris (ravulizumab-cwvz) is a brand-name drug prescribed for certain autoimmune conditions. Ultomiris is given as an intravenous (IV) infusion by a healthcare professional. The drug’s dosing ...
A higher daily dose of upadacitinib (Rinvoq) was associated with less severe disease and longer clinical remission for ulcerative colitis patients who responded to upadacitinib induction at 8 weeks, a ...
The high-dose regimen of SPINRAZA (nusinersen) is approved in the European Union and Japan. The high-dose regimen is under review with the United States Food and Drug Administration (FDA) and has a ...
The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...
SCOTTSDALE, AZ — In patients with Graves disease, prescribing a lower maintenance dose of methimazole (MMI) before discontinuing the drug is associated with significantly higher rates of remission, ...
Otezla (apremilast) comes as an oral tablet in three strengths: 10 milligrams (mg), 20 mg, and 30 mg. Otezla XR, an extended-release oral tablet, is available in one strength of 75 mg. The usual ...
Please provide your email address to receive an email when new articles are posted on . Guselkumab 200 mg every 4 weeks was more beneficial in patients with high disease activity and severity than 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results